HistoSonics announced that its Edison histotripsy system for noninvasively destroying liver tumors has secured early U.K.

Reuters reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the ...

Vivani Medical (Nasdaq:VANI) announced that it filed a Form 10 registration statement with the SEC to spin off its ...

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

Abbott (NYSE: ABT) published findings from the AVEIR DR i2i study evaluating the company's novel dual-chamber leadless ...

CoreMap announced that it received FDA investigational device exemption (IDE) to extend its electrophysiology (EP) mapping ...

The Financial Times reported yesterday that a duo of private equity firms approached Hologic (Nasdaq: HOLX) about a potential ...

Inspire Medical Systems (NYSE: INSP) announced that it recently launched the EuroStim registry evaluating its technology in ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced results from a study of its Monarch platform for robotic bronchoscopy ...

Distalmotion received FDA 510(k) clearance for the use of its Dexter surgical robot in adult cholecystectomy (gallbladder ...

Empatica announced today that it received CE mark approval for its EpiMonitor epilepsy monitoring solution. EpiMonitor, a ...

BD (NYSE: BDX) announced today that it plans to initiate a patient data registry for its Rotarex atherectomy system.